Q2 2024 · 13F-HR
Artal Group S.A.holdings as filed
Filed 2024-08-14 · accession 0001053906-24-000009
$3.92B
Reported value
112
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 148929102 | CAVA | Cava Group Inc | $2.18B | 55.6% | 23,507,990 | Common | SOLE |
| 528872302 | LXRX | Lexicon Pharmaceuticals Inc | $294.2M | 7.50% | 175,099,384 | Common | SOLE |
| 80706P103 | SRRK | Scholar Rock Holding Corp | $93.8M | 2.39% | 11,259,438 | Common | SOLE |
| 501575104 | KYMR | Kymera Therapeutics Inc | $89.7M | 2.29% | 3,005,610 | Common | SOLE |
| 61775R105 | MORFUSD | Morphic Holding Inc | $86.1M | 2.19% | 2,525,998 | Common | SOLE |
| 04280A100 | ARWR | Arrowhead Pharmaceuticals Inc | $82.9M | 2.11% | 3,189,389 | Common | SOLE |
| 03753U106 | APLSUSD | Apellis Pharmaceuticals Inc | $56.3M | 1.43% | 1,467,080 | Common | SOLE |
| 26818M108 | DYN | Dyne Therapeutics Inc | $53.5M | 1.36% | 1,516,960 | Common | SOLE |
| 82686Q101 | SLN | Silence Therapeutics PLC | $52.8M | 1.35% | 2,779,619 | Common | SOLE |
| 85205L107 | SWTXUSD | SpringWorks Therapeutics Inc | $49.5M | 1.26% | 1,313,026 | Common | SOLE |
| 22663K107 | CRNX | Crinetics Pharmaceuticals Inc | $47.7M | 1.22% | 1,066,064 | Common | SOLE |
| N5749R100 | 2GH | Merus NV | $45.0M | 1.15% | 760,355 | Common | SOLE |
| 07725L102 | ONC | Beigene Ltd | $43.3M | 1.10% | 303,369 | Common | SOLE |
| 76155X100 | RVMD | Revolution Medicines Inc | $39.4M | 1.01% | 1,015,776 | Common | SOLE |
| 50127T109 | KURA | Kura Oncology Inc | $37.5M | 0.96% | 1,819,884 | Common | SOLE |
| 92337R101 | VERA | Vera Therapeutics Inc | $33.1M | 0.84% | 915,974 | Common | SOLE |
| 640979100 | NMRA | Neumora Therapeutics Inc | $27.8M | 0.71% | 2,824,052 | Common | SOLE |
| 23282W605 | CYTK | Cytokinetics Inc | $26.8M | 0.68% | 494,421 | Common | SOLE |
| 05370A108 | RNAGBP | Avidity Biosciences Inc | $26.8M | 0.68% | 655,555 | Common | SOLE |
| 04280A100 | ARWR | Arrowhead Pharmaceuticals Inc | $26.0M | 0.66% | 1,000,000 | CALL | SOLE |
| 449585108 | 1K0 | IGM Biosciences Inc | $22.9M | 0.58% | 3,330,422 | Common | SOLE |
| Y95308105 | WVE | WAVE Life Sciences Ltd | $22.8M | 0.58% | 4,566,251 | Common | SOLE |
| 29479A108 | ERAS | Erasca Inc | $22.7M | 0.58% | 9,630,810 | Common | SOLE |
| 87583X109 | TNGX | Tango Therapeutics Inc | $21.6M | 0.55% | 2,519,841 | Common | SOLE |
| G72800108 | PRTA | Prothena Corporation PLC | $20.7M | 0.53% | 1,001,360 | Common | SOLE |
| 152309100 | CNTA | Centessa Pharmaceuticals PLC | $19.1M | 0.49% | 2,112,500 | Common | SOLE |
| 230031106 | CGEM | Cullinan Therapeutics Inc | $18.5M | 0.47% | 1,057,949 | Common | SOLE |
| N62509109 | NAMS | NewAmsterdam Pharma Company NV | $15.4M | 0.39% | 800,000 | Common | SOLE |
| 98420N105 | XENE | Xenon Pharmaceuticals Inc | $14.9M | 0.38% | 381,554 | Common | SOLE |
| 28036F105 | EWTX | Edgewise Therapeutics Inc | $14.6M | 0.37% | 811,718 | Common | SOLE |
| 83422E204 | SLDB | Solid Biosciences Inc | $14.2M | 0.36% | 2,500,000 | Common | SOLE |
| 500946108 | KRRO | Korro Bio Inc | $14.0M | 0.36% | 413,072 | Common | SOLE |
| 04351P101 | ASNDUSD | Ascendis Pharma A/S | $13.8M | 0.35% | 101,100 | Common | SOLE |
| 00847G804 | AGEN | Agenus Inc | $13.0M | 0.33% | 775,000 | Common | SOLE |
| 87184Q206 | SYRS | Syros Pharmaceuticals Inc | $12.9M | 0.33% | 2,505,013 | Common | SOLE |
| 38341P102 | GOSS | Gossamer Bio Inc | $12.0M | 0.31% | 13,308,968 | Common | SOLE |
| 24823R105 | DNLI | Denali Therapeutics Inc | $11.7M | 0.30% | 502,899 | Common | SOLE |
| 90400D108 | RARE | Ultragenyx Pharmaceutical Inc | $11.3M | 0.29% | 275,000 | Common | SOLE |
| G1110E107 | BHVN | Biohaven Ltd | $10.6M | 0.27% | 306,703 | Common | SOLE |
| 877619106 | TSHA | Taysha Gene Therapies Inc | $9.8M | 0.25% | 4,354,214 | Common | SOLE |
| 52886X107 | LXEO | Lexeo Therapeutics Inc | $9.7M | 0.25% | 603,435 | Common | SOLE |
| 00445A100 | — | ACELYRIN Inc | $8.9M | 0.23% | 2,020,888 | Common | SOLE |
| 47103J105 | JANX | Janux Therapeutics Inc | $8.5M | 0.22% | 203,000 | Common | SOLE |
| 816212302 | RNAC | Cartesian Therapeutics Inc | $8.2M | 0.21% | 304,554 | Common | SOLE |
| 75383L102 | RAPP | Rapport Therapeutics Inc | $8.1M | 0.21% | 350,000 | Common | SOLE |
| 462260100 | IOVA | Iovance Biotherapeutics Inc | $8.1M | 0.21% | 1,011,500 | Common | SOLE |
| 37148K100 | GBIOGBX | Generation Bio Co | $8.0M | 0.20% | 2,830,591 | Common | SOLE |
| 81578P106 | SEER | Seer Inc | $8.0M | 0.20% | 4,750,000 | Common | SOLE |
| 92673K108 | VIGL | Vigil Neuroscience Inc | $7.3M | 0.19% | 1,828,691 | Common | SOLE |
| 60255C885 | BRD1EUR | Mind Medicine MindMed Inc | $7.3M | 0.19% | 1,007,875 | Common | SOLE |
| 81141R100 | SE | Sea Ltd | $7.0M | 0.18% | 97,500 | Common | SOLE |
| 722304102 | PDD | PDD Holdings Inc | $6.0M | 0.15% | 45,500 | Common | SOLE |
| 67066G104 | NVDA | NVIDIA Corp | $5.3M | 0.14% | 43,000 | Common | SOLE |
| 594918104 | MSFT | Microsoft Corp | $5.1M | 0.13% | 11,300 | Common | SOLE |
| 92826C839 | V | Visa Inc | $5.0M | 0.13% | 19,000 | Common | SOLE |
| 09203E105 | BDTX | Black Diamond Therapeutics Inc | $4.9M | 0.12% | 1,046,517 | Common | SOLE |
| 268150109 | DT | Dynatrace Inc | $4.9M | 0.12% | 109,000 | Common | SOLE |
| 019818103 | — | Allovir Inc | $4.8M | 0.12% | 6,597,167 | Common | SOLE |
| 03828A101 | APLT | Applied Therapeutics Inc | $4.7M | 0.12% | 1,009,500 | Common | SOLE |
| 874039100 | TSM | Taiwan Semiconductor Manufacturing Co Ltd | $4.5M | 0.12% | 26,000 | Common | SOLE |
| 344174107 | FHTX | Foghorn Therapeutics Inc. | $4.1M | 0.11% | 720,720 | Common | SOLE |
| 23804L103 | DDOG | Datadog Inc | $3.8M | 0.10% | 28,925 | Common | SOLE |
| 02157Q109 | ANRO | Alto Neuroscience Inc | $3.7M | 0.10% | 350,000 | Common | SOLE |
| 023135106 | AMZN | Amazon Com Inc | $3.7M | 0.09% | 19,250 | Common | SOLE |
| 31189P102 | FATE | Fate Therapeutics Inc | $3.4M | 0.09% | 1,032,500 | Common | SOLE |
| 43906K100 | HOOKGBP | HOOKIPA Pharma Inc | $3.4M | 0.09% | 5,666,410 | Common | SOLE |
| H0036K147 | ADCT | ADC Therapeutics SA | $3.2M | 0.08% | 1,018,461 | Common | SOLE |
| 482497104 | BEKE | Ke Holdings Inc | $3.2M | 0.08% | 225,000 | Common | SOLE |
| 75901B107 | RGNX | Regenxbio Inc | $2.9M | 0.07% | 250,000 | Common | SOLE |
| 68217N105 | — | Omega Therapeutics Inc | $2.7M | 0.07% | 1,323,530 | Common | SOLE |
| 28623U101 | — | Elevation Oncology Inc | $2.7M | 0.07% | 1,013,015 | Common | SOLE |
| 49177J102 | KVUE | Kenvue Inc | $2.5M | 0.06% | 137,000 | Common | SOLE |
| 786700104 | SGMT | Sagimet Biosciences Inc | $2.5M | 0.06% | 724,771 | Common | SOLE |
| 38000Q102 | GLYCEUR | GlycoMimetics Inc | $2.4M | 0.06% | 8,589,064 | Common | SOLE |
| 74275K108 | PCOR | Procore Technologies Inc | $2.1M | 0.05% | 32,300 | Common | SOLE |
| 81762P102 | NOW | ServiceNow Inc | $2.0M | 0.05% | 2,500 | Common | SOLE |
| 690469101 | OVID | Ovid Therapeutics Inc | $1.9M | 0.05% | 2,500,000 | Common | SOLE |
| 39868T105 | 2JQ | Gritstone Bio Inc | $1.9M | 0.05% | 3,030,952 | Common | SOLE |
| 713317105 | PEPG | PepGen Inc | $1.8M | 0.05% | 113,317 | Common | SOLE |
| 697435105 | PANW | Palo Alto Networks Inc | $1.5M | 0.04% | 4,500 | Common | SOLE |
| 70450Y103 | PYPL | PayPal Holdings Inc | $1.5M | 0.04% | 26,000 | CALL | SOLE |
| 501976104 | KYTX | Kyverna Therapeutics Inc | $1.5M | 0.04% | 200,000 | Common | SOLE |
| 747525103 | QCOM | Qualcomm Inc | $1.5M | 0.04% | 7,500 | Common | SOLE |
| 008064107 | — | Aerovate Therapeutics Inc | $1.3M | 0.03% | 809,600 | Common | SOLE |
| 02079K305 | GOOGL | Alphabet Inc | $1.3M | 0.03% | 7,000 | Common | SOLE |
| 59102M104 | MGX | Metagenomi Inc | $1.2M | 0.03% | 300,000 | Common | SOLE |
| 89157D105 | TRML | Tourmaline Bio Inc | $1.2M | 0.03% | 91,426 | Common | SOLE |
| 781154109 | RBRK | Rubrik Inc | $1.1M | 0.03% | 35,000 | Common | SOLE |
| 50107A104 | KRON1USD | Kronos Bio Inc | $1.0M | 0.03% | 842,954 | Common | SOLE |
| 60937P106 | MDB | MongoDB Inc | $1.0M | 0.03% | 4,021 | Common | SOLE |
| 647581206 | EDU | New Oriental Education & Technology Group Inc | $971,625 | 0.02% | 12,500 | Common | SOLE |
| 48553T106 | BZ | Kanzhun Ltd | $940,500 | 0.02% | 50,000 | Common | SOLE |
| M6191J100 | FROG | Jfrog Ltd | $938,750 | 0.02% | 25,000 | Common | SOLE |
| 70450Y103 | PYPL | PayPal Holdings Inc | $870,450 | 0.02% | 15,000 | Common | SOLE |
| 458140100 | INTC | Intel Corp | $774,250 | 0.02% | 25,000 | Common | SOLE |
| 46333X108 | IRWD | Ironwood Pharmaceuticals Inc | $720,669 | 0.02% | 110,532 | Common | SOLE |
| 705573103 | PEGA | Pegasystems Inc | $696,095 | 0.02% | 11,500 | Common | SOLE |
| 833445109 | SNOW | Snowflake Inc | $682,340 | 0.02% | 5,051 | Common | SOLE |
| 00449L102 | 698 | Achilles Therapeutics PLC | $615,631 | 0.02% | 755,375 | Common | SOLE |
| 20717M103 | 8QR | Confluent Inc | $561,070 | 0.01% | 19,000 | Common | SOLE |
| 12510Q100 | CCC | CCC Intelligent Solutions Holdings Inc | $555,500 | 0.01% | 50,000 | Common | SOLE |
| 30303M102 | META | Meta Platforms Inc | $554,642 | 0.01% | 1,100 | Common | SOLE |
| 00724F101 | ADBE | Adobe Inc | $499,986 | 0.01% | 900 | Common | SOLE |
| 45827U109 | INTA | Intapp Inc | $476,710 | 0.01% | 13,000 | Common | SOLE |
| 88160R101 | TSLA | Tesla Inc | $395,760 | 0.01% | 2,000 | Common | SOLE |
| 75960P104 | RELY | Remitly Global Inc | $303,000 | 0.01% | 25,000 | Common | SOLE |
| 23255M204 | CYCN | Cyclerion Therapeutics Inc | $270,579 | 0.01% | 117,643 | Common | SOLE |
| 38341P102 | GOSS | Gossamer Bio Inc | $186,486 | 0.00% | 207,000 | CALL | SOLE |
| 142038108 | CRBU | Caribou Biosciences Inc | $172,769 | 0.00% | 105,347 | Common | SOLE |
| 24703L202 | DELL | Dell Technologies Inc | $137,910 | 0.00% | 1,000 | Common | SOLE |
| G29018101 | DLO | Dlocal Ltd | $84,799 | 0.00% | 10,482 | Common | SOLE |
| G7185D114 | — | Perception Capital Corp III | $3,547 | 0.00% | 126,666 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.